MARKET

PTCT

PTCT

Ptc Therapeutics
NASDAQ
75.02
-1.83
-2.38%
Closed 16:21 05/12 EDT
OPEN
76.87
PREV CLOSE
76.85
HIGH
76.87
LOW
74.14
VOLUME
2.21M
TURNOVER
0
52 WEEK HIGH
87.50
52 WEEK LOW
43.18
MARKET CAP
6.22B
P/E (TTM)
-32.4706
1D
5D
1M
3M
1Y
5Y
1D
PTC Therapeutics EVP, CLO Mark Elliott Boulding disposes 3,540 shares for $279,257.20
PUBT · 12h ago
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
TipRanks · 15h ago
Trump Trade: U.S. plans AI security order without required model tests
TipRanks · 1d ago
Trump approves plan to fire FDA head Marty Makary, CBS reports
TipRanks · 1d ago
PTC Therapeutics price target raised to $89 from $80 at JPMorgan
TipRanks · 1d ago
Weekly Report: what happened at PTCT last week (0504-0508)?
Weekly Report · 1d ago
Why PTC Therapeutics (PTCT) Is Up 12.5% After Beating Q1 Estimates And Lifting 2026 Guidance
Simply Wall St · 2d ago
Barclays Sticks to Its Buy Rating for PTC Therapeutics (PTCT)
TipRanks · 2d ago
More
About PTCT
PTC Therapeutics, Inc. is a global biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. It has two products, Translarna (ataluren) and Emflaza (deflazacort), for the treatment of Duchenne muscular dystrophy (DMD) a rare, life-threatening disorder. Its Upstaza, a gene therapy for the treatment of Aromatic L-Amino Decarboxylase (AADC) deficiency, a rare central nervous system (CNS) disorder. Its Tegsedi and Waylivra are for the treatment of rare diseases. Its Evrysdi, a treatment for spinal muscular atrophy (SMA).

Webull offers PTC Therapeutics, Inc. stock information, including NASDAQ: PTCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PTCT stock methods without spending real money on the virtual paper trading platform.